Search for: "R S V, Inc."
Results 101 - 120
of 30,601
Sorted by Relevance
|
Sort by Date
4 Apr 2012, 9:54 pm
DePuy Spine, Inc., the Federal Circuit vacated and remanded a decision by the Board of Patent Appeals and Interferences awarding priority to Appellee DePuy Spine, Inc. in an interference between DePuy's U.S. [read post]
4 Sep 2016, 7:32 am
In Hosford v. [read post]
19 Sep 2017, 5:58 am
”) ProgressOhio.org., Inc. v. [read post]
6 Sep 2015, 7:45 am
McIlwain v. [read post]
10 Apr 2015, 6:35 am
The recent case of Towe v. [read post]
27 May 2018, 2:05 pm
(U.S.S.C., March 20, 2018, Cyan, Inc. v. [read post]
7 Jan 2016, 7:49 am
Mary Meeks v. [read post]
23 Feb 2011, 9:59 pm
By Donald Zuhn -- Today, in Centocor Ortho Biotech, Inc. v. [read post]
12 Aug 2019, 9:54 pm
Hospira, Inc. and Eli Lilly & Co. v. [read post]
9 May 2019, 9:02 pm
But the Commission's powers are circumscribed in other ways, as illustrated by the Federal Circuit's decision last week in Amarin Pharma, Inc. v. [read post]
3 Sep 2019, 9:59 pm
Inc. v. [read post]
8 Oct 2021, 9:11 am
Information Builders, Inc., June 14, 2021, Taranto, R.). [read post]
15 May 2012, 4:00 am
The Ninth Circuit Court of Appeals held in Taproot Administrative Services, Inc. v. [read post]
10 Aug 2016, 8:47 am
In Scapa Dryer Fabrics, Inc. v. [read post]
5 Dec 2017, 9:59 pm
Greene's Energy Group, LLC is the argument before the Court in SAS Institute, Inc. v. [read post]
19 Apr 2020, 9:41 pm
Prometheus Labs., Inc. and Alice Corp. v. [read post]
11 Dec 2019, 9:27 pm
Supreme Court Rejects USPTO's Attempt to Recover Attorney's Fees in All District Court "Appeals" from PTAB Decisions By Joshua Rich -- In Peter v. [read post]
30 Mar 2020, 9:08 pm
Noonan -- The Federal Circuit affirmed the Patent Trial and Appeal Board's (PTAB) claim construction (and inter partes review (IPR) decision invalidating claims for obviousness) in it recent Genentech, Inc. v. [read post]
3 Feb 2016, 9:59 pm
Petsmart, Inc. [read post]
6 May 2019, 9:58 pm
Noonan -- Last Friday, the Federal Circuit affirmed a decision by the District Court that Defendants Actavis LLC and Teva Pharmaceuticals did not show by clear and convincing evidence that the claims asserted by Endo Pharmaceuticals Inc. and Mallinckrodt LLC were obvious, in Endo Pharmaceuticals Inc. v. [read post]
